Never miss the latest news and offers - subscribe now!
With several recent FDA approvals and a strong drug pipeline, the gene therapy market is coming of age and providing new hope for patients. As demand for these new therapies increases, a robust and scalable manufacturing process is critical. In this webinar, we will present an end user case study which illustrates the challenges and solutions to scale both the upstream and downstream process steps required to manufacture adenoviruses.
This webcast is being offered twice. Please select the webcast that is best for your time zone.
Best practices through implementation of the Biotech Integrated Solutions service architecture for large-scale manufacturing projects.